Safety lancet (XXXVII)
Tianjin Huahong Technology Co., Ltd. · Decision date Mar 31, 2026
What did the FDA decide?
FDA records K260191 as a 510(k) premarket notification, with a decision dated Mar 31, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Mar 31, 2026
Regulatory record facts
- Identifier
- K260191
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Tianjin Huahong Technology Co., Ltd.
- Product code
- FMK
- Decision code
- SESE
- Decision date
- Mar 31, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature.
- Applicant
- Tianjin Huahong Technology Co., Ltd.
- Product code
- FMK
- FDA device class
- 2
FDA decision timeline
K260191 received
Application receipt date recorded by FDA.
K260191 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FMK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Safety lancet (XL)K262526 | Tianjin Huahong Technology Co., Ltd. | 510(k) clearance | Sep 13, 2026 | FDA |
Verifine Safety LancetsK261045 | Promisemed Hangzhou Meditech Co., Ltd. | 510(k) clearance | May 1, 2026 | FDA |
Safety Heel LancetK253605 | Ningbo Medsun Medical Co., Ltd. | 510(k) clearance | Feb 20, 2026 | FDA |
| Tianjin Huahong Technology Co., Ltd. | 510(k) clearance | Feb 12, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tianjin Huahong Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tianjin
Sources and methodology
- Original FDA record: K260191
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
